Herbas VPB

Print
EN | LT
LT - GENETIC MARKERS FOR EFFICACY OF ILOPERIDONE IN THE TREATMENT OF PSYCHOTIC SYMPTOMS
EN - GENETIC MARKERS FOR EFFICACY OF ILOPERIDONE IN THE TREATMENT OF PSYCHOTIC SYMPTOMS

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C12Q 1/68
European patent
(11) Number of the document 3075865
(13) Kind of document T
(96) European patent application number 16161688.3
Date of filing the European patent application 2008-05-17
(97) Date of publication of the European application 2016-10-05
(45) Date of publication and mention of the grant of the patent 2018-05-09
(46) Date of publication of the claims translation
Priority applications
(30) Number Date Country code
939033 P 2007-05-18 US
Inventors
(72)
LAVEDAN, Christian, US
VOLPI, Simona, US
LICAMELE, Louis, US
Grantee
(73) Vanda Pharmaceuticals Inc., 9605 Medical Center Drive, Suite 300, Rockville NY 20850, US
Title
(54) GENETIC MARKERS FOR EFFICACY OF ILOPERIDONE IN THE TREATMENT OF PSYCHOTIC SYMPTOMS
  GENETIC MARKERS FOR EFFICACY OF ILOPERIDONE IN THE TREATMENT OF PSYCHOTIC SYMPTOMS